Transcriptional regulatory elements in the rat bradykinin B2 receptor gene

Immunopharmacology. 1996 Jun;33(1-3):36-41. doi: 10.1016/0162-3109(96)00080-x.

Abstract

In an attempt to elucidate the mechanisms underlying the regulation of bradykinin B2 receptor gene expression, the molecular structure of the rat gene including the 5'-flanking region was characterized (J. Biol. Chem. 269: 26920-26925, 1994). In this study we show that the gene spans about 32 kb, including a long first intron of 25 kb. The promoter region drives reporter gene expression in NG108-15 neuroglioma cells, and its expression is upregulated by cAMP, bradykinin, phorbol esters and by coexpression of an activated ras oncogene but not by dexamethasone.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Animals
  • Base Sequence
  • Bradykinin / pharmacology
  • DNA Primers / genetics
  • Gene Expression Regulation / drug effects
  • Genes, Regulator*
  • Genes, ras
  • Humans
  • Introns
  • Polymerase Chain Reaction
  • Promoter Regions, Genetic
  • Rats
  • Receptor, Bradykinin B2
  • Receptors, Bradykinin / genetics*
  • Sequence Homology, Nucleic Acid
  • Species Specificity
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tumor Cells, Cultured
  • Up-Regulation / drug effects

Substances

  • DNA Primers
  • Receptor, Bradykinin B2
  • Receptors, Bradykinin
  • 8-Bromo Cyclic Adenosine Monophosphate
  • Tetradecanoylphorbol Acetate
  • Bradykinin